RB1 and neoplasm: Though RB1 inhibition phenocopied the tumor initiating phenotypes observed in miR-181a overexpressing FTSECs, the nuclear defects and DNA damage phenotypes observed in the pshRB1 cells were consistently more diminished compared to the pmiR-181a cells (Supplementary Fig. 7C–F).